Activities of curcumin-related compounds in two cell lines persistently infected with different prion strains

Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells inf...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1866; no. 4; p. 130094
Main Authors Teruya, Kenta, Iwabuchi, Sara, Watanabe, Yuki, Tsuchida, Rikiya, Watanabe-Matsui, Miki, Konno, Hiroyuki, Doh-ura, Katsumi
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities. [Display omitted] •Two cells infected with different prion strains were treated with several compounds.•In one of the cells, the level of abnormal prion protein was reduced.•In the other cells, cross-linked dimer of abnormal prion protein was formed.•The different activities were explained with the characteristics of the compounds.•Preferable parameters for the respective activities of compounds were obtained.
AbstractList Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSᶜ). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSᶜ level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSᶜ was not observed; instead, two other compounds promoted the formation of covalently linked PrPSᶜ dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSᶜ level in the ScN2a cells and the dimer formation of PrPSᶜ in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.
Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities. [Display omitted] •Two cells infected with different prion strains were treated with several compounds.•In one of the cells, the level of abnormal prion protein was reduced.•In the other cells, cross-linked dimer of abnormal prion protein was formed.•The different activities were explained with the characteristics of the compounds.•Preferable parameters for the respective activities of compounds were obtained.
Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrP ). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains. Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds. In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrP level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrP was not observed; instead, two other compounds promoted the formation of covalently linked PrP dimers. Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrP level in the ScN2a cells and the dimer formation of PrP in the N167 cells, respectively. The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.
Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains.BACKGROUNDCultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with prion were treated with curcumin-related compounds. We found that the compounds behave differently in neuroblastoma neuro-2a (N2a) cells infected with different prion strains.Curcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds.METHODSCurcumin and related compounds were applied to the two types of persistently prion infected cells to analyze the different activities of the compounds.In ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers.RESULTSIn ScN2a cells, which were infected with the Rocky Mountain Laboratory prion strain, two of the six compounds significantly reduced the PrPSc level in a dose-dependent manner. On the other hand, in N167 cells, effective suppression of the total amount of PrPSc was not observed; instead, two other compounds promoted the formation of covalently linked PrPSc dimers.Chemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively.CONCLUSIONSChemometric analysis was used to determine the factors that contributed to the different effects of the six compounds. It showed that the ability to form hydrogen bonds, such as phenolic hydroxyl groups, and hydrophobic molecular properties predominantly contributed to the reduction of the PrPSc level in the ScN2a cells and the dimer formation of PrPSc in the N167 cells, respectively.The extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.GENERAL SIGNIFICANCEThe extracted information can be used to delineate the differences among prion strains and to design compounds that are directed toward their respective activities.
ArticleNumber 130094
Author Tsuchida, Rikiya
Teruya, Kenta
Watanabe-Matsui, Miki
Watanabe, Yuki
Konno, Hiroyuki
Iwabuchi, Sara
Doh-ura, Katsumi
Author_xml – sequence: 1
  givenname: Kenta
  surname: Teruya
  fullname: Teruya, Kenta
  email: kenta.teruya.d4@tohoku.ac.jp
  organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan
– sequence: 2
  givenname: Sara
  surname: Iwabuchi
  fullname: Iwabuchi, Sara
  organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan
– sequence: 3
  givenname: Yuki
  surname: Watanabe
  fullname: Watanabe, Yuki
  organization: Graduate School of Science and Engineering, Yamagata University, Yonezawa 992-8510, Japan
– sequence: 4
  givenname: Rikiya
  surname: Tsuchida
  fullname: Tsuchida, Rikiya
  organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan
– sequence: 5
  givenname: Miki
  surname: Watanabe-Matsui
  fullname: Watanabe-Matsui, Miki
  organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan
– sequence: 6
  givenname: Hiroyuki
  surname: Konno
  fullname: Konno, Hiroyuki
  organization: Graduate School of Science and Engineering, Yamagata University, Yonezawa 992-8510, Japan
– sequence: 7
  givenname: Katsumi
  surname: Doh-ura
  fullname: Doh-ura, Katsumi
  organization: Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35065183$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1u3SAQhVGUKLlJ-wZVxbIb3wIGbLqoFEX9kyJl066RDUPLlQ23gBPl7YPltIsu2s4GjeY7o-GcS3QaYgCEXlGyp4TKt4f9OA7fIewZYWxPW0IUP0E72nes6QmRp2hHWsIbTqW4QJc5H0gtocQ5umgFkYL27Q7N16b4e188ZBwdNksyy-xDk2AaClhs4nyMS7AZ-4DLQ8QGpglPPlT-CCn7XCCU6bGOHZhV8eDLD2y9c5DqBB-TjwHnkgYf8gt05oYpw8vn9wp9-_jh683n5vbu05eb69vGtEqURinrRiqAUas6BnYcuJDOWs4tGaVRpva9AiE7oTqq2OjG1gqiRN8paixvr9Cbbe8xxZ8L5KJnn9fLhwBxyZrJVgrRCd79B8oY61QvRUVfP6PLOIPV9WvzkB71LzcrwDfApJhzAvcboUSvoemD3kLTa2h6C63K3v0hM74Mpfq2ujb9S_x-E0P1895D0tl4CAasTzUQbaP_-4InxQe1kA
CitedBy_id crossref_primary_10_1096_fj_202400614R
crossref_primary_10_3987_REV_22_999
crossref_primary_10_1002_ptr_8119
Cites_doi 10.1073/pnas.0710054104
10.1371/journal.pone.0146021
10.1016/S0882-4010(05)80008-7
10.1038/nmeth.2089
10.1108/EBR-10-2013-0128
10.1002/bip.21022
10.1128/JVI.77.9.5499-5502.2003
10.1128/JVI.74.9.4377-4386.2000
10.1074/jbc.M113.531335
10.1007/s10930-010-9278-9
10.1186/s13024-016-0074-7
10.1007/s00705-008-0177-8
10.1074/jbc.274.25.17981
10.1038/s41598-018-25966-9
10.1523/JNEUROSCI.0547-11.2011
10.1073/pnas.65.1.129
10.1021/jm9601617
10.1016/S1056-8719(02)00166-1
10.1016/j.febslet.2015.05.039
10.1128/JVI.74.1.320-325.2000
10.1016/j.bmcl.2013.11.039
10.1371/journal.pone.0137958
10.1016/j.bbagen.2018.11.008
10.1016/j.bmcl.2014.10.076
10.1016/0092-8674(84)90533-6
10.1021/acs.jmedchem.5b00104
10.1021/bi2003907
10.1128/JVI.01563-07
10.1126/science.1183218
10.1016/j.bbrc.2011.01.030
10.1038/embor.2011.192
10.3390/foods6100092
10.1016/j.bbrc.2015.03.139
10.1016/j.bmcl.2019.06.052
10.1016/0092-8674(87)90150-4
10.1016/j.xphs.2019.03.025
10.3390/cells9020349
10.1016/j.jom.2012.06.002
10.1099/0022-1317-68-5-1391
10.1371/journal.pone.0084531
10.1016/j.molcel.2021.08.011
10.1016/j.saa.2014.05.096
10.1101/cshperspect.a023747
10.1074/jbc.274.30.20763
10.1074/jbc.272.10.6324
10.1073/pnas.95.23.13363
ContentType Journal Article
Copyright 2022 Elsevier B.V.
Copyright © 2022 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2022 Elsevier B.V.
– notice: Copyright © 2022 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2022.130094
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
ExternalDocumentID 35065183
10_1016_j_bbagen_2022_130094
S0304416522000125
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ID FETCH-LOGICAL-c395t-99dfb15e21d972edba456fdd44d0b6c9ca4589e567597192bfb3d50958791cd43
IEDL.DBID .~1
ISSN 0304-4165
1872-8006
IngestDate Fri Jul 11 07:55:43 EDT 2025
Fri Jul 11 00:43:50 EDT 2025
Thu Apr 03 07:08:21 EDT 2025
Tue Jul 01 00:22:16 EDT 2025
Thu Apr 24 23:00:34 EDT 2025
Fri Feb 23 02:41:52 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords F_unbound
PrPres
PrPSc
LP
DMSO
CNS
SA
Anti-prion
PLS
IC50
Curcumin
Partial least squares
Protein cross-linking
PBS
Acceptor
SDS
VDss
IR
MW
Rot_Bond
CNS_p
PrP
BBB_p
PrPC
Donor
Prion
PK
N2a
ATR
Language English
License Copyright © 2022 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c395t-99dfb15e21d972edba456fdd44d0b6c9ca4589e567597192bfb3d50958791cd43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 35065183
PQID 2622279865
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2636557547
proquest_miscellaneous_2622279865
pubmed_primary_35065183
crossref_primary_10_1016_j_bbagen_2022_130094
crossref_citationtrail_10_1016_j_bbagen_2022_130094
elsevier_sciencedirect_doi_10_1016_j_bbagen_2022_130094
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate April 2022
2022-04-00
20220401
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: April 2022
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta. General subjects
PublicationTitleAlternate Biochim Biophys Acta Gen Subj
PublicationYear 2022
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Prusiner, Groth, Bolton, Kent, Hood (bb0175) 1984; 38
Ishibashi, Homma, Nakagaki, Fuse, Sano, Takatsuki (bb0080) 2015; 10
Lafon, Imberdis, Wang (bb0105) 2018; 8
Caughey, Raymond, Raymond, Maxson, Silveira, Baron (bb0020) 2003; 77
Ritz, Baty, Streibig, Gerhard (bb0190) 2015; 10
Hair, Sarstedt, Hopkins, Kuppelwieser (bb0045) 2014; 26
Kawasaki, Kawagoe, Chen, Teruya, Sakasegawa, Doh-ura (bb0085) 2007; 81
Giles, Olson, Prusiner (bb0055) 2017
Urano, Takahachi, Higashiura, Fujiwara, Funamoto, Imai (bb0235) 2020; 9
Manolova, Deneva, Antonov, Drakalska, Momekova, Lambov (bb0120) 2014; 132
Prusiner (bb0170) 1998; 95
Olmsted, Carlson, Klebe, Ruddle, Rosenbaum (bb0145) 1970; 65
Nishizawa, Teruya, Oguma, Sakasegawa, Schätzl, Gilch (bb0140) 2019; 108
Baron, Hughson, Raymond, Offerdahl, Barton, Raymond (bb0010) 2011; 50
Hotsumi, Tajiri, Nikaido, Sato, Makabe, Konno (bb0070) 2019; 29
Naslavsky, Stein, Yanai, Friedlander, Taraboulos (bb0130) 1997; 272
Ayrolles-Torro, Imberdis, Torrent, Toupet, Baskakov, Poncet-Montange (bb0005) 2011; 31
Nishida, Harris, Vilette, Laude, Frobert, Grassi (bb0135) 2000; 74
Teruya, Nishizawa, Doh-ura (bb0215) 2010; 29
Kimura, Nishizawa, Oguma, Nishimura, Sakasegawa, Teruya (bb0090) 2015
R Core Team. R (bb0180) 2020
Stahl, Borchelt, Hsiao, Prusiner (bb0205) 1987; 51
Endo, Nikaido, Nakadate, Ise, Konno (bb0040) 2014; 24
Schneider, Rasband, Eliceiri (bb0195) 2012; 9
Chasseigneaux, Pastore, Britton-Davidian, Manié, Stern, Callebert (bb0025) 2008; 153
Wang, Boysen, Wood, Kansiz, McNaughton, Hearn (bb0240) 2008; 89
Cheng (bb0030) 2001; 46
Race, Fadness, Chesebro (bb0185) 1987; 68
Peng, Lai (bb0155) 2012; 30
Ortiz, Pastor, Palomer, Cruciani, Gago, Wade (bb0150) 1997; 40
Shaked, Fridlander, Meiner, Taraboulos, Gabizon (bb0200) 1999; 274
Doh-ura, Perryman, Race, Chesebro (bb0035) 1995; 18
Li, Browning, Mahal, Oelschlegel, Weissmann (bb0110) 2010; 327
Weissmann, Li, Mahal, Browning (bb0250) 2011; 12
Bosque, Prusiner (bb0015) 2000; 74
Imberdis, Ayrolles-Torro, Duarte Rodrigues, Torrent, Alvarez-Martinez, Kovacs (bb0075) 2016; 11
Konno, Endo, Ise, Miyazaki, Aoki, Sanjoh (bb0095) 2014; 24
Teruya, Doh-ura (bb0210) 2016
Ferreira, Marques, Conceição, Macedo, Machado, Mascarello (bb0050) 2014; 9
Hewlings, Kalman (bb0065) 2017; 6
Teruya, Nishizawa, Oguma, Sakasegawa, Kitamoto, Doh-ura (bb0220) 2019; 1863
Prabaningdyah, Riyanto, Rohman (bb0165) 2018; 8
Pires, Blundell, Ascher (bb0160) 2015; 58
Naslavsky, Shmeeda, Friedlander, Yanai, Futerman, Barenholz (bb0125) 1999; 274
Hamanaka, Sakasegawa, Ohmoto, Kimura, Ando, Doh-ura (bb0060) 2011; 405
Zanusso, Fiorini, Ferrari, Meade-White, Barbieri, Brocchi (bb0255) 2014; 289
Mahal, Baker, Demczyk, Smith, Julius, Weissmann (bb0115) 2007; 104
Teruya, Wakao, Sato, Hamanaka, Nishizawa, Funayama (bb0225) 2015; 460
Kraus, Hoyt, Schwartz (bb0100) 2021; 81
Wei, Simko, Levy, Xie, Jin, Zemla (bb0245) 2013; vol. 230
Li (10.1016/j.bbagen.2022.130094_bb0110) 2010; 327
Ayrolles-Torro (10.1016/j.bbagen.2022.130094_bb0005) 2011; 31
Ishibashi (10.1016/j.bbagen.2022.130094_bb0080) 2015; 10
Kraus (10.1016/j.bbagen.2022.130094_bb0100) 2021; 81
Nishida (10.1016/j.bbagen.2022.130094_bb0135) 2000; 74
Bosque (10.1016/j.bbagen.2022.130094_bb0015) 2000; 74
Lafon (10.1016/j.bbagen.2022.130094_bb0105) 2018; 8
Cheng (10.1016/j.bbagen.2022.130094_bb0030) 2001; 46
Ortiz (10.1016/j.bbagen.2022.130094_bb0150) 1997; 40
Hamanaka (10.1016/j.bbagen.2022.130094_bb0060) 2011; 405
Giles (10.1016/j.bbagen.2022.130094_bb0055) 2017
Naslavsky (10.1016/j.bbagen.2022.130094_bb0130) 1997; 272
Teruya (10.1016/j.bbagen.2022.130094_bb0210) 2016
Pires (10.1016/j.bbagen.2022.130094_bb0160) 2015; 58
Ferreira (10.1016/j.bbagen.2022.130094_bb0050) 2014; 9
Prabaningdyah (10.1016/j.bbagen.2022.130094_bb0165) 2018; 8
Chasseigneaux (10.1016/j.bbagen.2022.130094_bb0025) 2008; 153
Schneider (10.1016/j.bbagen.2022.130094_bb0195) 2012; 9
Ritz (10.1016/j.bbagen.2022.130094_bb0190) 2015; 10
Race (10.1016/j.bbagen.2022.130094_bb0185) 1987; 68
Stahl (10.1016/j.bbagen.2022.130094_bb0205) 1987; 51
Kawasaki (10.1016/j.bbagen.2022.130094_bb0085) 2007; 81
Teruya (10.1016/j.bbagen.2022.130094_bb0215) 2010; 29
Teruya (10.1016/j.bbagen.2022.130094_bb0220) 2019; 1863
Wang (10.1016/j.bbagen.2022.130094_bb0240) 2008; 89
Zanusso (10.1016/j.bbagen.2022.130094_bb0255) 2014; 289
Hewlings (10.1016/j.bbagen.2022.130094_bb0065) 2017; 6
R Core Team. R (10.1016/j.bbagen.2022.130094_bb0180)
Kimura (10.1016/j.bbagen.2022.130094_bb0090) 2015
Doh-ura (10.1016/j.bbagen.2022.130094_bb0035) 1995; 18
Mahal (10.1016/j.bbagen.2022.130094_bb0115) 2007; 104
Konno (10.1016/j.bbagen.2022.130094_bb0095) 2014; 24
Manolova (10.1016/j.bbagen.2022.130094_bb0120) 2014; 132
Endo (10.1016/j.bbagen.2022.130094_bb0040) 2014; 24
Naslavsky (10.1016/j.bbagen.2022.130094_bb0125) 1999; 274
Prusiner (10.1016/j.bbagen.2022.130094_bb0170) 1998; 95
Caughey (10.1016/j.bbagen.2022.130094_bb0020) 2003; 77
Urano (10.1016/j.bbagen.2022.130094_bb0235) 2020; 9
Shaked (10.1016/j.bbagen.2022.130094_bb0200) 1999; 274
Nishizawa (10.1016/j.bbagen.2022.130094_bb0140) 2019; 108
Weissmann (10.1016/j.bbagen.2022.130094_bb0250) 2011; 12
Baron (10.1016/j.bbagen.2022.130094_bb0010) 2011; 50
Prusiner (10.1016/j.bbagen.2022.130094_bb0175) 1984; 38
Teruya (10.1016/j.bbagen.2022.130094_bb0225) 2015; 460
Olmsted (10.1016/j.bbagen.2022.130094_bb0145) 1970; 65
Imberdis (10.1016/j.bbagen.2022.130094_bb0075) 2016; 11
Hotsumi (10.1016/j.bbagen.2022.130094_bb0070) 2019; 29
Wei (10.1016/j.bbagen.2022.130094_bb0245) 2013; vol. 230
Peng (10.1016/j.bbagen.2022.130094_bb0155) 2012; 30
Hair (10.1016/j.bbagen.2022.130094_bb0045) 2014; 26
References_xml – volume: 74
  start-page: 4377
  year: 2000
  end-page: 4386
  ident: bb0015
  article-title: Cultured Cell Sublines Highly Susceptible to Prion Infection
  publication-title: J. Virol.
– volume: 24
  start-page: 5621
  year: 2014
  end-page: 5626
  ident: bb0040
  article-title: Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 30
  start-page: 467
  year: 2012
  end-page: 480
  ident: bb0155
  article-title: Using partial least squares in operations management research: a practical guideline and summary of past research
  publication-title: J. Oper. Manag.
– volume: 405
  start-page: 285
  year: 2011
  end-page: 290
  ident: bb0060
  article-title: Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 26
  start-page: 106
  year: 2014
  end-page: 121
  ident: bb0045
  article-title: Partial least squares structural equation modeling (PLS-SEM): An emerging tool in business research
  publication-title: Eur. Bus. Rev.
– volume: 274
  start-page: 20763
  year: 1999
  end-page: 20771
  ident: bb0125
  article-title: Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions
  publication-title: J. Biol. Chem.
– volume: 50
  start-page: 4479
  year: 2011
  end-page: 4490
  ident: bb0010
  article-title: Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra
  publication-title: Biochemistry
– volume: 12
  start-page: 1109
  year: 2011
  end-page: 1117
  ident: bb0250
  article-title: Prions on the move
  publication-title: EMBO Rep.
– volume: 10
  year: 2015
  ident: bb0080
  article-title: Strain-dependent effect of macroautophagy on abnormally folded prion protein degradation in infected neuronal cells
  publication-title: PLoS One
– volume: 8
  start-page: 8023
  year: 2018
  ident: bb0105
  article-title: Low doses of bioherbicide favour prion aggregation and propagation in vivo
  publication-title: Sci. Rep.
– year: 2020
  ident: bb0180
  article-title: A Language and Environment for Statistical Computing
– volume: 40
  start-page: 1136
  year: 1997
  end-page: 1148
  ident: bb0150
  article-title: Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors
  publication-title: J. Med. Chem.
– volume: 46
  start-page: 61
  year: 2001
  end-page: 71
  ident: bb0030
  article-title: The power issue: determination of KB or Ki from IC50: a closer look at the Cheng–Prusoff equation, the Schild plot and related power equations
  publication-title: J. Pharmacol. Toxicol. Methods
– volume: 51
  start-page: 229
  year: 1987
  end-page: 240
  ident: bb0205
  article-title: Scrapie prion protein contains a phosphatidylinositol glycolipid
  publication-title: Cell.
– volume: 29
  start-page: 2157
  year: 2019
  end-page: 2161
  ident: bb0070
  article-title: Design, synthesis, and evaluation of a water soluble C5-monoketone type curcumin analogue as a potent amyloid β aggregation inhibitor
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 81
  start-page: 4540
  year: 2021
  end-page: 4551.e6
  ident: bb0100
  article-title: High-resolution structure and strain comparison of infectious mammalian prions
  publication-title: Mol. Cell
– volume: 9
  start-page: 349
  year: 2020
  ident: bb0235
  article-title: Curcumin derivative GT863 inhibits amyloid-beta production via inhibition of protein N-glycosylation
  publication-title: Cells.
– volume: 108
  start-page: 2814
  year: 2019
  end-page: 2820
  ident: bb0140
  article-title: Preparation and characterization of cellulose ether liposomes for the inhibition of prion formation in prion-infected cells
  publication-title: J. Pharm. Sci.
– volume: 327
  start-page: 869
  year: 2010
  end-page: 872
  ident: bb0110
  article-title: Darwinian evolution of prions in cell culture
  publication-title: Science
– volume: 58
  start-page: 4066
  year: 2015
  end-page: 4072
  ident: bb0160
  article-title: pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures
  publication-title: J. Med. Chem.
– volume: 10
  year: 2015
  ident: bb0190
  article-title: Dose-response analysis using R
  publication-title: PLoS One
– volume: 289
  start-page: 4870
  year: 2014
  end-page: 4881
  ident: bb0255
  article-title: Gerstmann-sträussler-scheinker disease and “anchorless prion protein” mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease
  publication-title: J. Biol. Chem.
– volume: 104
  start-page: 20908
  year: 2007
  end-page: 20913
  ident: bb0115
  article-title: Prion strain discrimination in cell culture: the cell panel assay
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 81
  start-page: 12889
  year: 2007
  end-page: 12898
  ident: bb0085
  article-title: Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner
  publication-title: J. Virol.
– volume: 74
  start-page: 320
  year: 2000
  end-page: 325
  ident: bb0135
  article-title: Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein
  publication-title: J. Virol.
– volume: 153
  start-page: 1693
  year: 2008
  end-page: 1702
  ident: bb0025
  article-title: Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines
  publication-title: Arch. Virol.
– volume: 18
  start-page: 1
  year: 1995
  end-page: 9
  ident: bb0035
  article-title: Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells
  publication-title: Microb. Pathog.
– volume: 38
  start-page: 127
  year: 1984
  end-page: 134
  ident: bb0175
  article-title: Purification and structural studies of a major scrapie prion protein
  publication-title: Cell.
– year: 2017
  ident: bb0055
  article-title: Developing therapeutics for PrP prion diseases
  publication-title: Cold Spring Harb. Perspect. Med.
– volume: 9
  start-page: 671
  year: 2012
  end-page: 675
  ident: bb0195
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
– volume: vol. 230
  start-page: 11
  year: 2013
  ident: bb0245
  article-title: corrplot: Visualization of a Correlation Matrix
– volume: 9
  year: 2014
  ident: bb0050
  article-title: Anti-prion activity of a panel of aromatic chemical compounds: in vitro in silico approaches
  publication-title: PLoS One
– volume: 272
  start-page: 6324
  year: 1997
  end-page: 6331
  ident: bb0130
  article-title: Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform *
  publication-title: J. Biol. Chem.
– volume: 65
  start-page: 129
  year: 1970
  end-page: 136
  ident: bb0145
  article-title: Isolation of microtubule protein from cultured mouse neuroblastoma cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 8
  start-page: 172
  year: 2018
  end-page: 179
  ident: bb0165
  article-title: Application of FTIR spectroscopy and multivariate calibration for analysis of curcuminoid in syrup formulation
  publication-title: J. Appl. Pharm. Sci.
– volume: 31
  start-page: 14882
  year: 2011
  end-page: 14892
  ident: bb0005
  article-title: Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity
  publication-title: J. Neurosci.
– volume: 132
  start-page: 815
  year: 2014
  end-page: 820
  ident: bb0120
  article-title: The effect of the water on the curcumin tautomerism: A quantitative approach
  publication-title: Spectrochim. Acta A Mol. Biomol. Spectrosc.
– volume: 68
  start-page: 1391
  year: 1987
  end-page: 1399
  ident: bb0185
  article-title: Characterization of scrapie infection in mouse neuroblastoma cells
  publication-title: J. Gen. Virol.
– volume: 460
  start-page: 989
  year: 2015
  end-page: 995
  ident: bb0225
  article-title: Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 6
  year: 2017
  ident: bb0065
  article-title: Curcumin: a review of its’ effects on human health
  publication-title: Foods
– volume: 95
  start-page: 13363
  year: 1998
  end-page: 13383
  ident: bb0170
  article-title: Prions
  publication-title: PNAS
– volume: 24
  start-page: 685
  year: 2014
  end-page: 690
  ident: bb0095
  article-title: Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1
  publication-title: Bioorg. Med. Chem. Lett.
– volume: 89
  start-page: 895
  year: 2008
  end-page: 905
  ident: bb0240
  article-title: Determination of the secondary structure of proteins in different environments by FTIR-ATR spectroscopy and PLS regression
  publication-title: Biopolymers.
– year: 2015
  ident: bb0090
  article-title: Secretin receptor involvement in prion-infected cells and animals
  publication-title: FEBS Lett.
– volume: 1863
  start-page: 384
  year: 2019
  end-page: 394
  ident: bb0220
  article-title: Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction
  publication-title: Biochim. Biophys. Acta Gen. Subj.
– volume: 11
  year: 2016
  ident: bb0075
  article-title: A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases
  publication-title: Mol. Neurodegener.
– year: 2016
  ident: bb0210
  article-title: Insights from Therapeutic Studies for PrP Prion Disease
  publication-title: Cold Spring Harb. Perspect. Med.
– volume: 274
  start-page: 17981
  year: 1999
  end-page: 17986
  ident: bb0200
  article-title: Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity
  publication-title: J. Biol. Chem.
– volume: 77
  start-page: 5499
  year: 2003
  end-page: 5502
  ident: bb0020
  article-title: Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin
  publication-title: J. Virol.
– volume: 29
  start-page: 493
  year: 2010
  end-page: 500
  ident: bb0215
  article-title: Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells
  publication-title: Protein J.
– volume: 104
  start-page: 20908
  year: 2007
  ident: 10.1016/j.bbagen.2022.130094_bb0115
  article-title: Prion strain discrimination in cell culture: the cell panel assay
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0710054104
– volume: vol. 230
  start-page: 11
  year: 2013
  ident: 10.1016/j.bbagen.2022.130094_bb0245
– volume: 10
  year: 2015
  ident: 10.1016/j.bbagen.2022.130094_bb0190
  article-title: Dose-response analysis using R
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0146021
– volume: 18
  start-page: 1
  year: 1995
  ident: 10.1016/j.bbagen.2022.130094_bb0035
  article-title: Identification of differentially expressed genes in scrapie-infected mouse neuroblastoma cells
  publication-title: Microb. Pathog.
  doi: 10.1016/S0882-4010(05)80008-7
– volume: 9
  start-page: 671
  year: 2012
  ident: 10.1016/j.bbagen.2022.130094_bb0195
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2089
– volume: 26
  start-page: 106
  year: 2014
  ident: 10.1016/j.bbagen.2022.130094_bb0045
  article-title: Partial least squares structural equation modeling (PLS-SEM): An emerging tool in business research
  publication-title: Eur. Bus. Rev.
  doi: 10.1108/EBR-10-2013-0128
– volume: 89
  start-page: 895
  year: 2008
  ident: 10.1016/j.bbagen.2022.130094_bb0240
  article-title: Determination of the secondary structure of proteins in different environments by FTIR-ATR spectroscopy and PLS regression
  publication-title: Biopolymers.
  doi: 10.1002/bip.21022
– volume: 77
  start-page: 5499
  year: 2003
  ident: 10.1016/j.bbagen.2022.130094_bb0020
  article-title: Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin
  publication-title: J. Virol.
  doi: 10.1128/JVI.77.9.5499-5502.2003
– volume: 74
  start-page: 4377
  year: 2000
  ident: 10.1016/j.bbagen.2022.130094_bb0015
  article-title: Cultured Cell Sublines Highly Susceptible to Prion Infection
  publication-title: J. Virol.
  doi: 10.1128/JVI.74.9.4377-4386.2000
– volume: 289
  start-page: 4870
  year: 2014
  ident: 10.1016/j.bbagen.2022.130094_bb0255
  article-title: Gerstmann-sträussler-scheinker disease and “anchorless prion protein” mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M113.531335
– volume: 29
  start-page: 493
  year: 2010
  ident: 10.1016/j.bbagen.2022.130094_bb0215
  article-title: Semisynthesis of a protein with cholesterol at the C-terminal, targeted to the cell membrane of live cells
  publication-title: Protein J.
  doi: 10.1007/s10930-010-9278-9
– volume: 11
  year: 2016
  ident: 10.1016/j.bbagen.2022.130094_bb0075
  article-title: A Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases
  publication-title: Mol. Neurodegener.
  doi: 10.1186/s13024-016-0074-7
– volume: 153
  start-page: 1693
  year: 2008
  ident: 10.1016/j.bbagen.2022.130094_bb0025
  article-title: Genetic heterogeneity versus molecular analysis of prion susceptibility in neuroblasma N2a sublines
  publication-title: Arch. Virol.
  doi: 10.1007/s00705-008-0177-8
– volume: 274
  start-page: 17981
  year: 1999
  ident: 10.1016/j.bbagen.2022.130094_bb0200
  article-title: Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.25.17981
– volume: 8
  start-page: 8023
  year: 2018
  ident: 10.1016/j.bbagen.2022.130094_bb0105
  article-title: Low doses of bioherbicide favour prion aggregation and propagation in vivo
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-25966-9
– volume: 31
  start-page: 14882
  year: 2011
  ident: 10.1016/j.bbagen.2022.130094_bb0005
  article-title: Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.0547-11.2011
– volume: 65
  start-page: 129
  year: 1970
  ident: 10.1016/j.bbagen.2022.130094_bb0145
  article-title: Isolation of microtubule protein from cultured mouse neuroblastoma cells
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.65.1.129
– volume: 40
  start-page: 1136
  year: 1997
  ident: 10.1016/j.bbagen.2022.130094_bb0150
  article-title: Reliability of comparative molecular field analysis models: effects of data scaling and variable selection using a set of human synovial fluid phospholipase A2 inhibitors
  publication-title: J. Med. Chem.
  doi: 10.1021/jm9601617
– volume: 46
  start-page: 61
  year: 2001
  ident: 10.1016/j.bbagen.2022.130094_bb0030
  article-title: The power issue: determination of KB or Ki from IC50: a closer look at the Cheng–Prusoff equation, the Schild plot and related power equations
  publication-title: J. Pharmacol. Toxicol. Methods
  doi: 10.1016/S1056-8719(02)00166-1
– year: 2015
  ident: 10.1016/j.bbagen.2022.130094_bb0090
  article-title: Secretin receptor involvement in prion-infected cells and animals
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2015.05.039
– volume: 74
  start-page: 320
  year: 2000
  ident: 10.1016/j.bbagen.2022.130094_bb0135
  article-title: Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein
  publication-title: J. Virol.
  doi: 10.1128/JVI.74.1.320-325.2000
– volume: 24
  start-page: 685
  year: 2014
  ident: 10.1016/j.bbagen.2022.130094_bb0095
  article-title: Synthesis and evaluation of curcumin derivatives toward an inhibitor of beta-site amyloid precursor protein cleaving enzyme 1
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2013.11.039
– volume: 10
  year: 2015
  ident: 10.1016/j.bbagen.2022.130094_bb0080
  article-title: Strain-dependent effect of macroautophagy on abnormally folded prion protein degradation in infected neuronal cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0137958
– volume: 1863
  start-page: 384
  year: 2019
  ident: 10.1016/j.bbagen.2022.130094_bb0220
  article-title: Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction
  publication-title: Biochim. Biophys. Acta Gen. Subj.
  doi: 10.1016/j.bbagen.2018.11.008
– volume: 24
  start-page: 5621
  year: 2014
  ident: 10.1016/j.bbagen.2022.130094_bb0040
  article-title: Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2014.10.076
– volume: 38
  start-page: 127
  year: 1984
  ident: 10.1016/j.bbagen.2022.130094_bb0175
  article-title: Purification and structural studies of a major scrapie prion protein
  publication-title: Cell.
  doi: 10.1016/0092-8674(84)90533-6
– volume: 58
  start-page: 4066
  year: 2015
  ident: 10.1016/j.bbagen.2022.130094_bb0160
  article-title: pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b00104
– volume: 8
  start-page: 172
  year: 2018
  ident: 10.1016/j.bbagen.2022.130094_bb0165
  article-title: Application of FTIR spectroscopy and multivariate calibration for analysis of curcuminoid in syrup formulation
  publication-title: J. Appl. Pharm. Sci.
– volume: 50
  start-page: 4479
  year: 2011
  ident: 10.1016/j.bbagen.2022.130094_bb0010
  article-title: Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra
  publication-title: Biochemistry
  doi: 10.1021/bi2003907
– volume: 81
  start-page: 12889
  year: 2007
  ident: 10.1016/j.bbagen.2022.130094_bb0085
  article-title: Orally administered amyloidophilic compound is effective in prolonging the incubation periods of animals cerebrally infected with prion diseases in a prion strain-dependent manner
  publication-title: J. Virol.
  doi: 10.1128/JVI.01563-07
– volume: 327
  start-page: 869
  year: 2010
  ident: 10.1016/j.bbagen.2022.130094_bb0110
  article-title: Darwinian evolution of prions in cell culture
  publication-title: Science
  doi: 10.1126/science.1183218
– volume: 405
  start-page: 285
  year: 2011
  ident: 10.1016/j.bbagen.2022.130094_bb0060
  article-title: Anti-prion activity of protein-bound polysaccharide K in prion-infected cells and animals
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2011.01.030
– volume: 12
  start-page: 1109
  year: 2011
  ident: 10.1016/j.bbagen.2022.130094_bb0250
  article-title: Prions on the move
  publication-title: EMBO Rep.
  doi: 10.1038/embor.2011.192
– volume: 6
  year: 2017
  ident: 10.1016/j.bbagen.2022.130094_bb0065
  article-title: Curcumin: a review of its’ effects on human health
  publication-title: Foods
  doi: 10.3390/foods6100092
– volume: 460
  start-page: 989
  year: 2015
  ident: 10.1016/j.bbagen.2022.130094_bb0225
  article-title: Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2015.03.139
– volume: 29
  start-page: 2157
  year: 2019
  ident: 10.1016/j.bbagen.2022.130094_bb0070
  article-title: Design, synthesis, and evaluation of a water soluble C5-monoketone type curcumin analogue as a potent amyloid β aggregation inhibitor
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2019.06.052
– year: 2016
  ident: 10.1016/j.bbagen.2022.130094_bb0210
  article-title: Insights from Therapeutic Studies for PrP Prion Disease
  publication-title: Cold Spring Harb. Perspect. Med.
– volume: 51
  start-page: 229
  year: 1987
  ident: 10.1016/j.bbagen.2022.130094_bb0205
  article-title: Scrapie prion protein contains a phosphatidylinositol glycolipid
  publication-title: Cell.
  doi: 10.1016/0092-8674(87)90150-4
– volume: 108
  start-page: 2814
  year: 2019
  ident: 10.1016/j.bbagen.2022.130094_bb0140
  article-title: Preparation and characterization of cellulose ether liposomes for the inhibition of prion formation in prion-infected cells
  publication-title: J. Pharm. Sci.
  doi: 10.1016/j.xphs.2019.03.025
– volume: 9
  start-page: 349
  year: 2020
  ident: 10.1016/j.bbagen.2022.130094_bb0235
  article-title: Curcumin derivative GT863 inhibits amyloid-beta production via inhibition of protein N-glycosylation
  publication-title: Cells.
  doi: 10.3390/cells9020349
– volume: 30
  start-page: 467
  year: 2012
  ident: 10.1016/j.bbagen.2022.130094_bb0155
  article-title: Using partial least squares in operations management research: a practical guideline and summary of past research
  publication-title: J. Oper. Manag.
  doi: 10.1016/j.jom.2012.06.002
– volume: 68
  start-page: 1391
  year: 1987
  ident: 10.1016/j.bbagen.2022.130094_bb0185
  article-title: Characterization of scrapie infection in mouse neuroblastoma cells
  publication-title: J. Gen. Virol.
  doi: 10.1099/0022-1317-68-5-1391
– volume: 9
  year: 2014
  ident: 10.1016/j.bbagen.2022.130094_bb0050
  article-title: Anti-prion activity of a panel of aromatic chemical compounds: in vitro in silico approaches
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0084531
– ident: 10.1016/j.bbagen.2022.130094_bb0180
– volume: 81
  start-page: 4540
  issue: 21
  year: 2021
  ident: 10.1016/j.bbagen.2022.130094_bb0100
  article-title: High-resolution structure and strain comparison of infectious mammalian prions
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2021.08.011
– volume: 132
  start-page: 815
  year: 2014
  ident: 10.1016/j.bbagen.2022.130094_bb0120
  article-title: The effect of the water on the curcumin tautomerism: A quantitative approach
  publication-title: Spectrochim. Acta A Mol. Biomol. Spectrosc.
  doi: 10.1016/j.saa.2014.05.096
– year: 2017
  ident: 10.1016/j.bbagen.2022.130094_bb0055
  article-title: Developing therapeutics for PrP prion diseases
  publication-title: Cold Spring Harb. Perspect. Med.
  doi: 10.1101/cshperspect.a023747
– volume: 274
  start-page: 20763
  year: 1999
  ident: 10.1016/j.bbagen.2022.130094_bb0125
  article-title: Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.274.30.20763
– volume: 272
  start-page: 6324
  year: 1997
  ident: 10.1016/j.bbagen.2022.130094_bb0130
  article-title: Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform *
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.10.6324
– volume: 95
  start-page: 13363
  year: 1998
  ident: 10.1016/j.bbagen.2022.130094_bb0170
  article-title: Prions
  publication-title: PNAS
  doi: 10.1073/pnas.95.23.13363
SSID ssj0000595
Score 2.3903499
Snippet Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSc). In this study, two types of cells persistently infected with...
Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrP ). In this study, two types of cells persistently infected with...
Cultured cell lines infected with prions produce an abnormal isoform of the prion protein (PrPSᶜ). In this study, two types of cells persistently infected with...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 130094
SubjectTerms Anti-prion
Cell Line
chemometrics
Curcumin
Curcumin - pharmacology
dose response
hydrogen
hydrophobicity
Partial least squares
Prion
Prion Proteins
prions
Prions - chemistry
Prions - metabolism
Protein cross-linking
PrPSc Proteins - metabolism
Title Activities of curcumin-related compounds in two cell lines persistently infected with different prion strains
URI https://dx.doi.org/10.1016/j.bbagen.2022.130094
https://www.ncbi.nlm.nih.gov/pubmed/35065183
https://www.proquest.com/docview/2622279865
https://www.proquest.com/docview/2636557547
Volume 1866
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEB_EIu1LabUf11aJ4Gs8d5Psbh6Po3JV9MUKvoXLx8IV3Ttu9yi-9G_vTLJr8cEKPmZJYJiZzPySnckP4CiTmQuZ8rjTrOay9oFXNhdcUD5AvCHmlpqTLy6L2bU8u1E3WzAdemGorLKP_Smmx2jdfxn32hyvFovxFf3UQziBACJep1CjuZQlefnxn39lHggfVPqTIDnNHtrnYo2Xtbhp6RXUPI-0yFo-lZ6egp8xDZ2-g7c9fmSTJOJ72ArNLuwkRsn7XXg9HQjc9uBu4iI1BJ6F2bJmbrN2m7tFw2P7SvCMqsmJVKlli4Z1v5eMLvEZwc6WregaDR2g6W7vWSrYwhV0acsGSpWOrdZoVNZGlon2A1yffv85nfGeXYE7oVXHtfa1zVTIM6_LPHg7RyxVey-lP7GF0w7HlQ4KTxS6RBxoays8wgtVlTpzXoqPsN0sm_AZGIYFTLXeuaISsqIzlLY2O8EEaXUIVo5ADEo1rn96nGS7NUON2S-TTGHIFCaZYgT8YdUqPb3xzPxysJd55EIGs8MzKw8H8xq0EWl73oTlpjV5Qb3CuirU_-aIQiHqleUIPiXfeJBXKIR4qJ4vL5btK7yhUSoW-gbb3XoT9hEHdfYgOvoBvJr8OJ9d_gXb4AeI
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7ShJJeSpO-to9EgVzVjS3Jto5hadjmdWkCuYnVw7Al8S5rLyWX_vbOSHZKD2mgR9sSDDOjmU_yjD6Aw0xmLmTK40qzmsvaB17ZXHBB-QDxhphZak6-uCym1_L0Rt1swGTohaGyyj72p5geo3X_Ztxrc7ycz8ff6acewgkEEPE4RT2DLYnLl2gMvvz6U-eB-EGlXwmS0_Chfy4WeVmLq5auQc3zyIus5WP56TH8GfPQySt42QNIdpxk3IGN0OzC80Qpeb8L25OBwe013B27yA2Bm2G2qJlbr9z6bt7w2L8SPKNycmJVatm8Yd3PBaNTfEa4s2VLOkdDD2i623uWKrZwBp3asoFTpWPLFVqVtZFmon0D1ydfryZT3tMrcCe06rjWvraZCnnmdZkHb2cIpmrvpfRHtnDa4XOlg8IthS4RCNraCo_4QlWlzpyX4i1sNosmvAeGcQFzrXeuqISsaBOlrc2OMENaHYKVIxCDUo3r7x4n2W7NUGT2wyRTGDKFSaYYAX-YtUx3bzwxvhzsZf7yIYPp4YmZB4N5DdqItD1rwmLdmrygZmFdFepfY0ShEPbKcgTvkm88yCsUYjxUz4f_lm0ftqdXF-fm_Nvl2Ud4QV9S5dAn2OxW6_AZQVFn96LT_wbIlAkW
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activities+of+curcumin-related+compounds+in+two+cell+lines+persistently+infected+with+different+prion+strains&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Teruya%2C+Kenta&rft.au=Iwabuchi%2C+Sara&rft.au=Watanabe%2C+Yuki&rft.au=Tsuchida%2C+Rikiya&rft.date=2022-04-01&rft.issn=0304-4165&rft.volume=1866&rft.issue=4&rft.spage=130094&rft_id=info:doi/10.1016%2Fj.bbagen.2022.130094&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bbagen_2022_130094
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon